Similar articles for PMID: 22978763

Year	Number of Results
1997	1
2005	1
2007	3
2008	3
2009	5
2010	6
2011	8
2012	9
2013	9
2014	12
2015	7
2016	11
2017	17
2018	12
2019	11
2020	4
2021	6
2022	5
2023	1
2024	0

1

Exclusive image guided IMRT vs. radical prostatectomy followed by postoperative IMRT for localized prostate cancer: a matched-pair analysis based on risk-groups.

Azelie C, Gauthier M, Mirjolet C, Cormier L, Martin E, Peignaux-Casasnovas K, Truc G, Chamois J, Maingon P, Créhange G. Azelie C, et al. Radiat Oncol. 2012 Sep 17;7:158. doi: 10.1186/1748-717X-7-158. Radiat Oncol. 2012. PMID: 22978763 Free PMC article.

2

Improvement in toxicity in high risk prostate cancer patients treated with image-guided intensity-modulated radiotherapy compared to 3D conformal radiotherapy without daily image guidance.

Sveistrup J, af Rosenschöld PM, Deasy JO, Oh JH, Pommer T, Petersen PM, Engelholm SA. Sveistrup J, et al. Radiat Oncol. 2014 Feb 4;9:44. doi: 10.1186/1748-717X-9-44. Radiat Oncol. 2014. PMID: 24495815 Free PMC article.

3

Dual-timing PSA as a biomarker for patients with salvage intensity modulated radiation therapy for biochemical failure after radical prostatectomy.

Wang YJ, Huang CY, Hou WH, Wang CC, Lan KH, Yu HJ, Lai MK, Liu SP, Pu YS, Cheng JC. Wang YJ, et al. Oncotarget. 2016 Jul 12;7(28):44224-44235. doi: 10.18632/oncotarget.10000. Oncotarget. 2016. PMID: 27317764 Free PMC article.

4

Clinical impact of margin reduction on late toxicity and short-term biochemical control for patients treated with daily on-line image guided IMRT for prostate cancer.

Crehange G, Mirjolet C, Gauthier M, Martin E, Truc G, Peignaux-Casasnovas K, Azelie C, Bonnetain F, Naudy S, Maingon P. Crehange G, et al. Radiother Oncol. 2012 May;103(2):244-6. doi: 10.1016/j.radonc.2011.10.025. Epub 2011 Nov 25. Radiother Oncol. 2012. PMID: 22119374

5

Impact of image guidance on toxicity and tumour outcome in moderately hypofractionated external-beam radiotherapy for prostate cancer.

Jereczek-Fossa BA, Maucieri A, Marvaso G, Gandini S, Fodor C, Zerini D, Riva G, Alessandro O, Surgo A, Volpe S, Fanetti G, Arculeo S, Zerella MA, Parisi S, Maisonneuve P, Vavassori A, Cattani F, Cambria R, Garibaldi C, Starzyńska A, Musi G, De Cobelli O, Ferro M, Nolè F, Ciardo D, Orecchia R. Jereczek-Fossa BA, et al. Med Oncol. 2018 Nov 27;36(1):9. doi: 10.1007/s12032-018-1233-1. Med Oncol. 2018. PMID: 30483899

6

Treatment outcome of high-dose image-guided intensity-modulated radiotherapy using intra-prostate fiducial markers for localized prostate cancer at a single institute in Japan.

Takeda K, Takai Y, Narazaki K, Mitsuya M, Umezawa R, Kadoya N, Fujita Y, Sugawara T, Kubozono M, Shimizu E, Abe K, Shirata Y, Ishikawa Y, Yamamoto T, Kozumi M, Dobashi S, Matsushita H, Chida K, Ishidoya S, Arai Y, Jingu K, Yamada S. Takeda K, et al. Radiat Oncol. 2012 Jul 6;7:105. doi: 10.1186/1748-717X-7-105. Radiat Oncol. 2012. PMID: 22770471 Free PMC article.

7

Comparison of Image-Guided Intensity-Modulated Radiotherapy and Low-dose Rate Brachytherapy with or without External Beam Radiotherapy in Patients with Localized Prostate Cancer.

Tsubokura T, Yamazaki H, Masui K, Sasaki N, Shimizu D, Suzuki G, Nakamura S, Yamada K, Okihara K, Shiraishi T, Yoshida K, Nishikawa T, Okabe H. Tsubokura T, et al. Sci Rep. 2018 Jul 12;8(1):10538. doi: 10.1038/s41598-018-28730-1. Sci Rep. 2018. PMID: 30002393 Free PMC article.

8

Toxicity after post-prostatectomy image-guided intensity-modulated radiotherapy using Australian guidelines.

Chin S, Aherne NJ, Last A, Assareh H, Shakespeare TP. Chin S, et al. J Med Imaging Radiat Oncol. 2017 Dec;61(6):804-811. doi: 10.1111/1754-9485.12632. Epub 2017 Jun 17. J Med Imaging Radiat Oncol. 2017. PMID: 28623847

9

Long-term decision regret after post-prostatectomy image-guided intensity-modulated radiotherapy.

Shakespeare TP, Chin S, Manuel L, Wen S, Hoffman M, Wilcox SW, Aherne NJ. Shakespeare TP, et al. J Med Imaging Radiat Oncol. 2017 Feb;61(1):141-145. doi: 10.1111/1754-9485.12508. Epub 2016 Aug 16. J Med Imaging Radiat Oncol. 2017. PMID: 27531363

10

Long-term Tumor Control and Late Toxicity in Patients with Prostate Cancer Receiving Hypofractionated (2.2 Gy) Soft-tissue-matched Image-guided Intensity-modulated Radiotherapy.

Shimizu D, Yamazaki H, Nishimura T, Aibe N, Okabe H. Shimizu D, et al. Anticancer Res. 2017 Oct;37(10):5829-5835. doi: 10.21873/anticanres.12026. Anticancer Res. 2017. PMID: 28982908

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

108 results

Results by year